Abstract:A novel diagnostic scheme that includes pancreatic β‑cell dysfunction analysis for the diagnosis of traumatic multiple organ dysfunction syndrome (MODS) was investigated to assist in the early diagnosis and detection of MODS. Early intervention and treatment of MODS has been associated with a reduced mortality rate. A total of 2,876 trauma patients (including patients post‑major surgery) were admitted to the intensive care unit of the authors' hospital between December 2010 and December 2015 and enrolled in the present study. There were 205 cases where the patient succumbed to their injuries. In addition to the conventional diagnostic scheme for traumatic MODS, indexes of pancreatic β‑cell dysfunction [fasting blood‑glucose (FBG), homeostatic model assessment‑β and (blood insulin concentration 30 min following glucose loading‑fasting insulin concentration)/(blood glucose concentration 30 min following glucose loading‑FBG concentration)] were included to establish an improved diagnostic scheme for traumatic MODS. The novel scheme was subsequently used in clinical practice alongside the conventional scheme and its effect was evaluated. The novel scheme had a significantly higher positive number of MODS diagnoses for all trauma patients compared with the conventional scheme (12.48 vs. 8.87%; P<0.01). No significant difference was identified in the final percentage of positive of MODS diagnoses for trauma‑associated mortality patients between the novel (88.30%) and the conventional scheme (86.34%). The novel scheme had a significantly higher positive number of MODS diagnoses for trauma‑associated mortality patients 3 days prior to patients succumbing to MODS compared with the conventional scheme (80.98 vs. 64.39%; P<0.01). The consensus of the MODS diagnosis of all trauma patients between the novel scheme and the conventional scheme was 100%; however, out of the patients diagnosed as positive by novel scheme 71.03% were positive by the conventional scheme. The consensus between the final MODS diagnosis and the MODS diagnosis 3 days prior to patients succumbing to their injuries between the novel scheme and the conventional scheme was 100%; however, out of the patients diagnosed as positive by novel scheme 97.79 were positive by the conventional scheme of the 205 patients who succumbed to MODS and out of the patients diagnosed as positive for MODS by novel scheme 3 days prior to succumbing, 79.52% were positive by the conventional scheme. The results of the present study demonstrated that the novel diagnostic scheme using the relevant indexes of pancreatic β‑cell dysfunction for diagnosis of traumatic MODS, was able to diagnose MODS early without excessively extending the diagnostic scope. Its clinical application should be promoted.

Systemic Metabolic Changes of Traumatic Critically Ill Patients Revealed by an NMR-based Metabonomic Approach.

Metabolic Abnormalities in Patients with Chronic Disorders of Consciousness.

Metabolic Dynamics in Critically Injured Patients: a Prospective Cohort Study Integrated with 1H NMR Metabolomics.

A metabonomic approach to early prognostic evaluation of experimental sepsis by 1H NMR and pattern recognition

Discrimination of Sepsis Stage Metabolic Profiles with an LC/MS-MS-based Metabolomics Approach.

Multi-center Clinical Study on the Diagnostic Criteria for Multiple Organ Dysfunction Syndrome with Illness Severity Score System

Use of 1 H-nuclear magnetic resonance to screen a set of biomarkers for monitoring metabolic disturbances in severe burn patients

Analysis of metabolic disturbances attributable to sepsis-induced myocardial dysfunction using metabolomics and transcriptomics techniques

1H-nuclear magnetic resonance analysis reveals dynamic changes in the metabolic profile of patients with severe burns

Nuclear magnetic resonance-based serum metabolomic analysis reveals different disease evolution profiles between septic shock survivors and non-survivors

Establishing ¹H Nuclear Magnetic Resonance Based Metabonomics Fingerprinting Profile for Spinal Cord Injury: a Pilot Study.

Clinical Application of a Novel Diagnostic Scheme Including Pancreatic Β‑cell Dysfunction for Traumatic Multiple Organ Dysfunction Syndrome.

A Clinical Study on the Diagnostic Criteria of Multiple Organ Dysfunction Syndrome

A Metabonomic Approach to Prognostic Evaluation of ALI by High-Resolution Nuclear Magnetic Resonance (HR NMR) Spectroscopy

Integrative analysis of metabolomics and proteomics reveals amino acid metabolism disorder in sepsis

Landscape of Metabolic Fingerprinting for Diagnosis and Risk Stratification of Sepsis

Metabolomics study of Shenling Baizhu Powder in the treatment of multiple organ dysfunction syndrome in the elderly (MODSE) with malnutrition

Exploring the Biomarkers of Sepsis-Associated Encephalopathy (SAE): Metabolomics Evidence from Gas Chromatography-Mass Spectrometry

Accuracy of nuclear magnetic resonance spectroscopy-based metabonomic technique in predicting prognosis in septic rats

A metabonomic approach to early prognostic evaluation of experimental sepsis.

Nutrient pattern analysis in critically ill patients using Omics technology (NAChO) - Study protocol for a prospective observational study